Your browser doesn't support javascript.
loading
SISCOS in focal cortical dysplasia: localization and comparative analysis with MRI.
Khan, Dikhra; Sagar, Sambit; Jaleel, Jasim; Umar, Mohammad; Tripathi, Madhavi; Tripathi, Manjari; Sharma, M C; Bal, Chandrasekhar.
Afiliação
  • Khan D; Department of Nuclear Medicine, PET/CT, All India Institute of Medical Sciences, New Delhi, 110029, India.
  • Sagar S; Department of Nuclear Medicine, PET/CT, All India Institute of Medical Sciences, New Delhi, 110029, India.
  • Jaleel J; Department of Nuclear Medicine, PET/CT, All India Institute of Medical Sciences, New Delhi, 110029, India.
  • Umar M; Department of Nuclear Medicine, PET/CT, All India Institute of Medical Sciences, New Delhi, 110029, India.
  • Tripathi M; Department of Nuclear Medicine, PET/CT, All India Institute of Medical Sciences, New Delhi, 110029, India. madhavi.dave.97@gmail.com.
  • Tripathi M; Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
  • Sharma MC; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
  • Bal C; Department of Nuclear Medicine, PET/CT, All India Institute of Medical Sciences, New Delhi, 110029, India.
Neuroradiology ; 2024 Jul 26.
Article em En | MEDLINE | ID: mdl-39060800
ABSTRACT

PURPOSE:

This study evaluates the efficacy of SISCOS (Subtraction ictal-interictal SPECT coregistered to SPECT) in localizing the epileptogenic zone (EZ) in focal cortical dysplasia (FCD), comparing its predictive performance with MRI and post-surgical outcomes based on ILAE classification.

METHODS:

84 patients with drug refractory epilepsy (DRE) who were operated and had histopathology consistent with FCD, were included in the study. All patients had undergone a complete work-up including SISCOS and MRI for EZ localization, followed by discussion in the multidisciplinary epilepsy surgery meeting prior to surgery. Ictal & interictal perfusion SPECT studies were performed with Tc-99 m Ethylene Cysteinate Dimer (Tc-99 m ECD) followed by SISCOS analysis using SPM2 and Bioimage Suite 2.6. Concordance for localization was determined by comparing with the surgical resection site and post-surgical outcomes were assessed using the ILAE classification.

RESULTS:

The concordance for EZ localization demonstrated by SISCOS was 73.8% and MRI was 82.1%. 52 patients (61.9%) had good surgical outcome and 31(59%) of these were FCD type 2. In patients with discordant MRI findings, SISCOS was able to provide localisation in 86% (13/15), with 69.2% showing good surgical outcomes. Sensitivity of SISCOS and MRI was 73% (95% CI = 59-84.8%) and 78% (95% CI = 67.5-90.3%) respectively with no significant difference between the two. In FCD type I, both SISCOS and MRI revealed a similar a sensitivity of 76.4% (95%CI = 50.1-93.2%). Concordant cases exhibited higher seizure-free odds ratios for both modalities.

CONCLUSION:

SISCOS is effective in localizing the EZ in FCD patients, comparable to MRI. Integrating SISCOS and MRI enhances lesion detection, especially in MRI discordant cases. A comprehensive diagnostic approach utilizing SISCOS and MRI can optimize the non-invasive pre-surgical assessment in DRE thereby guiding surgical decision-making in a resource-limited setting.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article